We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Fujifilm

Offers diagnostic imaging products, including FCR” digital x-ray imaging and diagnostic systems, “Synapse” medical-us... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Disruptive Technology Enables Endoscopists to Measure Polyps More Accurately

By HospiMedica International staff writers
Posted on 26 Apr 2023
Print article
Image: SCALE EYE aids endoscopists in estimating the size of lesions in the colon (Photo courtesy of FUJIFILM)
Image: SCALE EYE aids endoscopists in estimating the size of lesions in the colon (Photo courtesy of FUJIFILM)

Colorectal cancer is the second most common cancer in Europe, accounting for 12.7% of all new cancer diagnoses in 2020. Early detection and diagnosis of cancer and pre-cancerous lesions can significantly improve patient outcomes. When determining therapeutic interventions in the colon, such as resect and discard, EMR, and ESD, lesion size is considered a crucial factor. However, estimating lesion size in the endoscopic field of view is not always easy. Now, a real-time virtual scale function has been developed to help endoscopists estimate the size of colon lesions more accurately.

Although 90% of endoscopists agree on the importance of polyp measurement, most rely on visual estimation, open biopsy forceps, or endoscopic rulers rather than innovative solutions. A survey of 300 endoscopists revealed that nearly 70% believe accurate polyp measurement is essential for precise diagnosis. The majority of endoscopists find it challenging to measure polyps accurately, with nearly three-quarters stating that a more precise tool is needed. To address this need, FUJIFILM Europe (Ratingen, Germany) has introduced SCALE EYE, a virtual scale solution designed to assist endoscopists in accurately estimating the size of colon lesions. According to the survey, 88% of endoscopists found that characterizing polyps, which is also possible through Fujifilm's CAD-EYE technology, is essential for accurate diagnosis.

Integrated into FUJIFILM's ELUXEO Ultra platform, SCALE EYE allows endoscopists to measure polyps more accurately, helping physicians determine the appropriate treatment with just a simple switch press. The virtual scale can be activated or deactivated by pressing the switch on the endoscope or the processor itself. The endoscope switch allocation can be configured in the endoscope setup menu. SCALE EYE is designed to support endoscopists performing colonoscopies by providing size estimations of targeted lesions and clinically relevant artifacts, which could significantly impact clinical diagnoses.

“Our new research clearly illustrates that SCALE EYE is yet another technological leap forward in the fight against colorectal cancer,” said Saskia Papa, Senior Product Manager at FUJIFILM Europe GmbH. “These study results echo what we've been hearing, across all our markets, about the potentially transformational role of this visual scale solution in ensuring the detection and accurate characterization of lesions. With SCALE EYE, we have a real chance to further support physicians in improving the quality of colonoscopy, from screening to treatment and ultimately to improve the lives of patients.”

Related Links:
FUJIFILM Europe 

Gold Supplier
Creatinine Meter
StatSensor Xpress Creatinine Meter
New
Multi-Parameter Patient Monitor
S80
New
Patient Transfer Stretcher
TT-Patient Transfer Stretcher
New
Gynecological Examination & Treatment Chair
medi-matic

Print article
FIME - Informa

Channels

AI

view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.